I ask unanimous consent that my law clerk, Jeff Gary, be granted floor privileges for the remainder of this Congress. The PRESIDING OFFICER. Without objection, it is so ordered. ____________________

What we ought to be concerned about is if there's a secret interpretation that's different than what people read.

I am very favorably inclined towards your candidacy here, your nomination.

Millions of Americans are employed in the service sector in fields like science and technology, which accounted for about a third of U.S. exports.

Transparency goes right to the heart of what I think a smart trade policy is.

It's long been my view that NAFTA should be completely overhauled.

If there is a plan to deal with China's trade practices, this committee and the American people want to know what it is.

I support both of these nominees this morning, Mr. Chairman.

This administration, including the Office of the U.S. Trade Representative, has fallen short on transparency and consultations with Congress, stakeholders and the public.

If an intelligence operation is inconsistent with the public's understanding of the law, that is a prescription for trouble.

I thank my colleagues. I will be very brief. Colleagues, what we are debating is whether the Senate will be the Senate. If you vote in favor of this, you are voting for cloture, there will be no amendments then. We would have the…

I ask unanimous consent to speak for up to 2 minutes. The PRESIDING OFFICER. Is there objection? Without objection, it is so ordered.

I want to thank Chairman Leahy for his excellent remarks. Let me simply say, to move forward without amendments surrenders the constitutional obligations Senators have to the American people. This issue is important, it is complicated, and…

The same Donald Trump who said almost exactly one year ago that price-hiking drug companies were 'getting away with murder' has nominated a drug company executive.

I appreciate your interest in getting this done. I spoke on CHIP on the floor yesterday.

I would like the measure of success to be finding jobs for people so you can get out of poverty.

That is not the question. Did you ever lower the price? That is the question I----

To me, risking the Medicaid guarantee so essential for long-term care for the eligible seniors--I want everybody to know that is a non-starter here.

No amount of flexibility is going to compensate for those types of cuts.

Let the record show that when that specific question for Mr. Azar was asked--did he ever lower the price of a Lilly drug sold in the United States, Mr. Azar said 'no.'

The President's first budget proposed cutting Medicaid by hundreds of billions of dollars through proposals like block grants.

To say this administration hasn't yet delivered would be a wild understatement.

Endangering the health of low-income Americans, in my view, is the absolute wrong way to go.

You have always been a gentleman. Every member of this body feels that.

As chairman of the Pricing, Reimbursement, and Access Steering Committee for Lilly USA and as the relevant profit and loss business unit leader for the biomedicines business unit for the United States, I approved pricing recommendations…